<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rossi I</submitter><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><pagination>539-542</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7870514</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>169(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Obesity and type 2 diabetes mellitus are associated with elevated levels of inflammatory markers. This chronic inflammation is known to contribute to increased risk of cardiovascular disease in these populations. Laparoscopic Roux-en-Y gastric bypass is associated with a high rate of diabetes remission. We hypothesize that laparoscopic Roux-en-Y gastric bypass decreases systemic inflammatory markers and cardiovascular disease risk factors in obese diabetics.&lt;h4>Methods&lt;/h4>This was a single-institution prospective cohort study of 61 obese patients with type 2 diabetes mellitus. A total of 30 patients underwent laparoscopic Roux-en-Y gastric bypass surgery, and 31 patients underwent standard medical therapy with diabetes support and education. Collected data included preo</pubmed_abstract><journal>Surgery</journal><pubmed_title>Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics.</pubmed_title><pmcid>PMC7870514</pmcid><funding_grant_id>K23 DK075907</funding_grant_id><pubmed_authors>Torquati A</pubmed_authors><pubmed_authors>Rossi I</pubmed_authors><pubmed_authors>Spagnoli A</pubmed_authors><pubmed_authors>Poirier J</pubmed_authors><pubmed_authors>Omotosho P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics.</name><description>&lt;h4>Background&lt;/h4>Obesity and type 2 diabetes mellitus are associated with elevated levels of inflammatory markers. This chronic inflammation is known to contribute to increased risk of cardiovascular disease in these populations. Laparoscopic Roux-en-Y gastric bypass is associated with a high rate of diabetes remission. We hypothesize that laparoscopic Roux-en-Y gastric bypass decreases systemic inflammatory markers and cardiovascular disease risk factors in obese diabetics.&lt;h4>Methods&lt;/h4>This was a single-institution prospective cohort study of 61 obese patients with type 2 diabetes mellitus. A total of 30 patients underwent laparoscopic Roux-en-Y gastric bypass surgery, and 31 patients underwent standard medical therapy with diabetes support and education. Collected data included preo</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-18T12:11:44.078Z</modification><creation>2025-04-06T21:48:22.072Z</creation></dates><accession>S-EPMC7870514</accession><cross_references><pubmed>33168209</pubmed><doi>10.1016/j.surg.2020.09.039</doi></cross_references></HashMap>